nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—KDR—age related macular degeneration	0.832	1	CbGaD
Ponatinib—FGFR4—connective tissue—age related macular degeneration	0.00426	0.108	CbGeAlD
Ponatinib—LYN—connective tissue—age related macular degeneration	0.00292	0.0743	CbGeAlD
Ponatinib—FGFR3—connective tissue—age related macular degeneration	0.0029	0.0739	CbGeAlD
Ponatinib—BCR—eye—age related macular degeneration	0.00261	0.0664	CbGeAlD
Ponatinib—FLT3—connective tissue—age related macular degeneration	0.0025	0.0635	CbGeAlD
Ponatinib—RET—connective tissue—age related macular degeneration	0.002	0.0509	CbGeAlD
Ponatinib—FGFR2—eye—age related macular degeneration	0.00197	0.0502	CbGeAlD
Ponatinib—FGFR2—connective tissue—age related macular degeneration	0.0019	0.0484	CbGeAlD
Ponatinib—TEK—connective tissue—age related macular degeneration	0.00182	0.0464	CbGeAlD
Ponatinib—SRC—eye—age related macular degeneration	0.00168	0.0428	CbGeAlD
Ponatinib—SRC—retina—age related macular degeneration	0.00167	0.0424	CbGeAlD
Ponatinib—PDGFRA—connective tissue—age related macular degeneration	0.00165	0.042	CbGeAlD
Ponatinib—SRC—connective tissue—age related macular degeneration	0.00162	0.0412	CbGeAlD
Ponatinib—KDR—eye—age related macular degeneration	0.00155	0.0394	CbGeAlD
Ponatinib—KDR—retina—age related macular degeneration	0.00153	0.039	CbGeAlD
Ponatinib—KDR—connective tissue—age related macular degeneration	0.00149	0.0379	CbGeAlD
Ponatinib—KIT—connective tissue—age related macular degeneration	0.00132	0.0336	CbGeAlD
Ponatinib—ABL1—eye—age related macular degeneration	0.00119	0.0304	CbGeAlD
Ponatinib—ABL1—retina—age related macular degeneration	0.00118	0.0301	CbGeAlD
Ponatinib—ABL1—connective tissue—age related macular degeneration	0.00115	0.0293	CbGeAlD
Ponatinib—ABCB1—retina—age related macular degeneration	0.000368	0.00936	CbGeAlD
Ponatinib—FGFR2—Adaptive Immune System—C3—age related macular degeneration	5.39e-05	0.000418	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—KDR—age related macular degeneration	5.37e-05	0.000417	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—CD36—age related macular degeneration	5.37e-05	0.000416	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—RHO—age related macular degeneration	5.36e-05	0.000415	CbGpPWpGaD
Ponatinib—FGFR2—Innate Immune System—CRP—age related macular degeneration	5.34e-05	0.000414	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TGFBR1—age related macular degeneration	5.33e-05	0.000413	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—CD36—age related macular degeneration	5.3e-05	0.000411	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—C3—age related macular degeneration	5.29e-05	0.00041	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—CD36—age related macular degeneration	5.28e-05	0.00041	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—CRP—age related macular degeneration	5.24e-05	0.000406	CbGpPWpGaD
Ponatinib—FGFR2—Disease—TGFBR1—age related macular degeneration	5.24e-05	0.000406	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—C3—age related macular degeneration	5.23e-05	0.000405	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—C3—age related macular degeneration	5.21e-05	0.000404	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	5.2e-05	0.000403	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—ELOVL4—age related macular degeneration	5.2e-05	0.000403	CbGpPWpGaD
Ponatinib—SRC—Immune System—CFH—age related macular degeneration	5.15e-05	0.0004	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—NMNAT1—age related macular degeneration	5.15e-05	0.000399	CbGpPWpGaD
Ponatinib—KIT—Disease—TGFBR1—age related macular degeneration	5.14e-05	0.000399	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—SQSTM1—age related macular degeneration	5.14e-05	0.000399	CbGpPWpGaD
Ponatinib—FGFR2—Innate Immune System—TLR4—age related macular degeneration	5.12e-05	0.000397	CbGpPWpGaD
Ponatinib—KIT—Immune System—SQSTM1—age related macular degeneration	5.05e-05	0.000392	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—ABCA4—age related macular degeneration	5.05e-05	0.000391	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—TLR4—age related macular degeneration	5.02e-05	0.00039	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—C3—age related macular degeneration	5.02e-05	0.000389	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—CD36—age related macular degeneration	5.01e-05	0.000389	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—C3—age related macular degeneration	5.01e-05	0.000388	CbGpPWpGaD
Ponatinib—SRC—Immune System—CFB—age related macular degeneration	5e-05	0.000387	CbGpPWpGaD
Ponatinib—LYN—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	4.98e-05	0.000386	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—CRP—age related macular degeneration	4.97e-05	0.000386	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—CRP—age related macular degeneration	4.96e-05	0.000385	CbGpPWpGaD
Ponatinib—FGFR1—Disease—TGFBR1—age related macular degeneration	4.88e-05	0.000378	CbGpPWpGaD
Ponatinib—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	4.87e-05	0.000378	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—TGFBR1—age related macular degeneration	4.87e-05	0.000378	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—CD36—age related macular degeneration	4.85e-05	0.000376	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—SQSTM1—age related macular degeneration	4.83e-05	0.000375	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—CD36—age related macular degeneration	4.83e-05	0.000375	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—KDR—age related macular degeneration	4.83e-05	0.000375	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—SQSTM1—age related macular degeneration	4.79e-05	0.000372	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—SQSTM1—age related macular degeneration	4.78e-05	0.000371	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—TLR4—age related macular degeneration	4.77e-05	0.00037	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—TLR4—age related macular degeneration	4.76e-05	0.000369	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—KDR—age related macular degeneration	4.75e-05	0.000368	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—C3—age related macular degeneration	4.75e-05	0.000368	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—KDR—age related macular degeneration	4.73e-05	0.000367	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—CD36—age related macular degeneration	4.66e-05	0.000361	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TGFBR1—age related macular degeneration	4.65e-05	0.00036	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—CCL2—age related macular degeneration	4.61e-05	0.000358	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—C3—age related macular degeneration	4.6e-05	0.000357	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—C3—age related macular degeneration	4.58e-05	0.000355	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—LIPC—age related macular degeneration	4.53e-05	0.000351	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—CRP—age related macular degeneration	4.52e-05	0.00035	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ELOVL4—age related macular degeneration	4.5e-05	0.000349	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—NMNAT1—age related macular degeneration	4.49e-05	0.000348	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—ABCA4—age related macular degeneration	4.47e-05	0.000346	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—CD36—age related macular degeneration	4.42e-05	0.000343	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—C3—age related macular degeneration	4.42e-05	0.000342	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—RHO—age related macular degeneration	4.39e-05	0.00034	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—CRP—age related macular degeneration	4.38e-05	0.000339	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—CETP—age related macular degeneration	4.37e-05	0.000339	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—CRP—age related macular degeneration	4.36e-05	0.000338	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—TLR4—age related macular degeneration	4.33e-05	0.000336	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—NMNAT1—age related macular degeneration	4.23e-05	0.000328	CbGpPWpGaD
Ponatinib—LYN—Immune System—SQSTM1—age related macular degeneration	4.22e-05	0.000327	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—SQSTM1—age related macular degeneration	4.21e-05	0.000327	CbGpPWpGaD
Ponatinib—ABL1—Immune System—SQSTM1—age related macular degeneration	4.2e-05	0.000325	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—TLR4—age related macular degeneration	4.2e-05	0.000325	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—SLC16A8—age related macular degeneration	4.19e-05	0.000325	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—TLR4—age related macular degeneration	4.18e-05	0.000324	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	4.17e-05	0.000323	CbGpPWpGaD
Ponatinib—FGFR1—Axon guidance—VEGFA—age related macular degeneration	4.17e-05	0.000323	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—C3—age related macular degeneration	4.15e-05	0.000322	CbGpPWpGaD
Ponatinib—FGFR3—Disease—APOE—age related macular degeneration	4.08e-05	0.000317	CbGpPWpGaD
Ponatinib—LCK—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	4.08e-05	0.000317	CbGpPWpGaD
Ponatinib—SRC—Focal Adhesion—VEGFA—age related macular degeneration	4.08e-05	0.000316	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	4.06e-05	0.000315	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—VEGFA—age related macular degeneration	4.04e-05	0.000313	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	4.02e-05	0.000312	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—CD36—age related macular degeneration	3.99e-05	0.000309	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—CD36—age related macular degeneration	3.98e-05	0.000308	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ELOVL4—age related macular degeneration	3.92e-05	0.000304	CbGpPWpGaD
Ponatinib—LCK—Disease—CST3—age related macular degeneration	3.92e-05	0.000304	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—CD36—age related macular degeneration	3.91e-05	0.000303	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—RHO—age related macular degeneration	3.89e-05	0.000301	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—APOE—age related macular degeneration	3.87e-05	0.0003	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—CD36—age related macular degeneration	3.82e-05	0.000296	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—KDR—age related macular degeneration	3.79e-05	0.000294	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—C3—age related macular degeneration	3.77e-05	0.000292	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	3.7e-05	0.000287	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TGFBR1—age related macular degeneration	3.67e-05	0.000284	CbGpPWpGaD
Ponatinib—LYN—Axon guidance—VEGFA—age related macular degeneration	3.67e-05	0.000284	CbGpPWpGaD
Ponatinib—ABL1—Axon guidance—VEGFA—age related macular degeneration	3.65e-05	0.000283	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—SLC16A8—age related macular degeneration	3.63e-05	0.000281	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—C3—age related macular degeneration	3.62e-05	0.000281	CbGpPWpGaD
Ponatinib—SRC—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	3.61e-05	0.00028	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TGFBR1—age related macular degeneration	3.6e-05	0.000279	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—CRP—age related macular degeneration	3.59e-05	0.000278	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—CD36—age related macular degeneration	3.52e-05	0.000273	CbGpPWpGaD
Ponatinib—LCK—Disease—TGFBR1—age related macular degeneration	3.52e-05	0.000273	CbGpPWpGaD
Ponatinib—SRC—Disease—CST3—age related macular degeneration	3.47e-05	0.000269	CbGpPWpGaD
Ponatinib—LCK—Immune System—SQSTM1—age related macular degeneration	3.46e-05	0.000268	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CD36—age related macular degeneration	3.45e-05	0.000267	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—KDR—age related macular degeneration	3.45e-05	0.000267	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—TLR4—age related macular degeneration	3.44e-05	0.000267	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TGFBR1—age related macular degeneration	3.42e-05	0.000265	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TGFBR1—age related macular degeneration	3.41e-05	0.000264	CbGpPWpGaD
Ponatinib—KIT—Immune System—CD36—age related macular degeneration	3.39e-05	0.000263	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—CD36—age related macular degeneration	3.38e-05	0.000262	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—C3—age related macular degeneration	3.34e-05	0.000259	CbGpPWpGaD
Ponatinib—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	3.33e-05	0.000259	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—SQSTM1—age related macular degeneration	3.33e-05	0.000258	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—C3—age related macular degeneration	3.27e-05	0.000253	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—SQSTM1—age related macular degeneration	3.27e-05	0.000253	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—CCL2—age related macular degeneration	3.25e-05	0.000252	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CD36—age related macular degeneration	3.21e-05	0.000249	CbGpPWpGaD
Ponatinib—KIT—Immune System—C3—age related macular degeneration	3.21e-05	0.000249	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CD36—age related macular degeneration	3.21e-05	0.000249	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—C3—age related macular degeneration	3.21e-05	0.000249	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—CRP—age related macular degeneration	3.18e-05	0.000246	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—SLC16A8—age related macular degeneration	3.16e-05	0.000245	CbGpPWpGaD
Ponatinib—SRC—Disease—TGFBR1—age related macular degeneration	3.12e-05	0.000242	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CRP—age related macular degeneration	3.11e-05	0.000241	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—SQSTM1—age related macular degeneration	3.1e-05	0.00024	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—SQSTM1—age related macular degeneration	3.09e-05	0.00024	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—C3—age related macular degeneration	3.07e-05	0.000238	CbGpPWpGaD
Ponatinib—SRC—Immune System—SQSTM1—age related macular degeneration	3.06e-05	0.000237	CbGpPWpGaD
Ponatinib—KIT—Immune System—CRP—age related macular degeneration	3.05e-05	0.000237	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—C3—age related macular degeneration	3.05e-05	0.000236	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—TLR4—age related macular degeneration	3.04e-05	0.000236	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—C3—age related macular degeneration	3.04e-05	0.000235	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TGFBR1—age related macular degeneration	3.01e-05	0.000233	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—LIPC—age related macular degeneration	2.99e-05	0.000232	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—TLR4—age related macular degeneration	2.98e-05	0.000231	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	2.98e-05	0.000231	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—VEGFA—age related macular degeneration	2.97e-05	0.000231	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—VEGFA—age related macular degeneration	2.96e-05	0.00023	CbGpPWpGaD
Ponatinib—KIT—Immune System—TLR4—age related macular degeneration	2.93e-05	0.000227	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CRP—age related macular degeneration	2.9e-05	0.000225	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CRP—age related macular degeneration	2.89e-05	0.000224	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—CETP—age related macular degeneration	2.89e-05	0.000224	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—APOE—age related macular degeneration	2.86e-05	0.000222	CbGpPWpGaD
Ponatinib—LYN—Immune System—CD36—age related macular degeneration	2.83e-05	0.000219	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CD36—age related macular degeneration	2.81e-05	0.000218	CbGpPWpGaD
Ponatinib—FGFR2—Disease—APOE—age related macular degeneration	2.81e-05	0.000218	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—KDR—age related macular degeneration	2.8e-05	0.000217	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—TLR4—age related macular degeneration	2.78e-05	0.000215	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—TLR4—age related macular degeneration	2.77e-05	0.000215	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	2.76e-05	0.000214	CbGpPWpGaD
Ponatinib—KIT—Disease—APOE—age related macular degeneration	2.76e-05	0.000214	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—SQSTM1—age related macular degeneration	2.73e-05	0.000211	CbGpPWpGaD
Ponatinib—LYN—Immune System—C3—age related macular degeneration	2.68e-05	0.000208	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—C3—age related macular degeneration	2.68e-05	0.000207	CbGpPWpGaD
Ponatinib—ABL1—Immune System—C3—age related macular degeneration	2.67e-05	0.000207	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—VEGFA—age related macular degeneration	2.66e-05	0.000206	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—CD36—age related macular degeneration	2.63e-05	0.000204	CbGpPWpGaD
Ponatinib—FGFR1—Disease—APOE—age related macular degeneration	2.62e-05	0.000203	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—VEGFA—age related macular degeneration	2.62e-05	0.000203	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—APOE—age related macular degeneration	2.61e-05	0.000202	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—VEGFA—age related macular degeneration	2.6e-05	0.000202	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—VEGFA—age related macular degeneration	2.57e-05	0.000199	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—VEGFA—age related macular degeneration	2.56e-05	0.000198	CbGpPWpGaD
Ponatinib—LYN—Immune System—CRP—age related macular degeneration	2.55e-05	0.000198	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CRP—age related macular degeneration	2.54e-05	0.000197	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—APOE—age related macular degeneration	2.49e-05	0.000193	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TGFBR1—age related macular degeneration	2.47e-05	0.000191	CbGpPWpGaD
Ponatinib—LYN—Immune System—TLR4—age related macular degeneration	2.44e-05	0.000189	CbGpPWpGaD
Ponatinib—ABL1—Immune System—TLR4—age related macular degeneration	2.43e-05	0.000189	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	2.42e-05	0.000188	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	2.42e-05	0.000187	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—CCL2—age related macular degeneration	2.4e-05	0.000186	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	2.4e-05	0.000186	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD36—age related macular degeneration	2.32e-05	0.00018	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—APOE—age related macular degeneration	2.32e-05	0.00018	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—SQSTM1—age related macular degeneration	2.23e-05	0.000173	CbGpPWpGaD
Ponatinib—LCK—Immune System—C3—age related macular degeneration	2.2e-05	0.00017	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TGFBR1—age related macular degeneration	2.18e-05	0.000169	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—LIPC—age related macular degeneration	2.14e-05	0.000166	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	2.13e-05	0.000165	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—C3—age related macular degeneration	2.11e-05	0.000164	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—VEGFA—age related macular degeneration	2.1e-05	0.000163	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—CCL2—age related macular degeneration	2.09e-05	0.000162	CbGpPWpGaD
Ponatinib—LCK—Immune System—CRP—age related macular degeneration	2.09e-05	0.000162	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—VEGFA—age related macular degeneration	2.09e-05	0.000162	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—C3—age related macular degeneration	2.07e-05	0.000161	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—CETP—age related macular degeneration	2.07e-05	0.00016	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD36—age related macular degeneration	2.05e-05	0.000159	CbGpPWpGaD
Ponatinib—LCK—Immune System—TLR4—age related macular degeneration	2e-05	0.000155	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—SQSTM1—age related macular degeneration	1.98e-05	0.000153	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—C3—age related macular degeneration	1.97e-05	0.000153	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—APOE—age related macular degeneration	1.97e-05	0.000152	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—C3—age related macular degeneration	1.96e-05	0.000152	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	1.95e-05	0.000151	CbGpPWpGaD
Ponatinib—SRC—Immune System—C3—age related macular degeneration	1.94e-05	0.000151	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—APOE—age related macular degeneration	1.93e-05	0.00015	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—KDR—age related macular degeneration	1.93e-05	0.000149	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—VEGFA—age related macular degeneration	1.9e-05	0.000147	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—KDR—age related macular degeneration	1.89e-05	0.000147	CbGpPWpGaD
Ponatinib—LCK—Disease—APOE—age related macular degeneration	1.89e-05	0.000146	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—VEGFA—age related macular degeneration	1.86e-05	0.000144	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—LIPC—age related macular degeneration	1.86e-05	0.000144	CbGpPWpGaD
Ponatinib—SRC—Immune System—CRP—age related macular degeneration	1.85e-05	0.000143	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—APOE—age related macular degeneration	1.83e-05	0.000142	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—APOE—age related macular degeneration	1.83e-05	0.000142	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—KDR—age related macular degeneration	1.8e-05	0.000139	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CETP—age related macular degeneration	1.79e-05	0.000139	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—KDR—age related macular degeneration	1.79e-05	0.000139	CbGpPWpGaD
Ponatinib—SRC—Immune System—TLR4—age related macular degeneration	1.77e-05	0.000137	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—CD36—age related macular degeneration	1.74e-05	0.000135	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—C3—age related macular degeneration	1.73e-05	0.000134	CbGpPWpGaD
Ponatinib—SRC—Disease—APOE—age related macular degeneration	1.67e-05	0.00013	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CCL2—age related macular degeneration	1.65e-05	0.000128	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CCL2—age related macular degeneration	1.62e-05	0.000126	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—LIPC—age related macular degeneration	1.62e-05	0.000125	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—APOE—age related macular degeneration	1.61e-05	0.000125	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—KDR—age related macular degeneration	1.58e-05	0.000122	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CETP—age related macular degeneration	1.56e-05	0.000121	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—VEGFA—age related macular degeneration	1.54e-05	0.00012	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CCL2—age related macular degeneration	1.54e-05	0.000119	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CCL2—age related macular degeneration	1.54e-05	0.000119	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—APOE—age related macular degeneration	1.53e-05	0.000119	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—LIPC—age related macular degeneration	1.53e-05	0.000118	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CETP—age related macular degeneration	1.47e-05	0.000114	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—C3—age related macular degeneration	1.42e-05	0.00011	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CCL2—age related macular degeneration	1.36e-05	0.000105	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—VEGFA—age related macular degeneration	1.34e-05	0.000104	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—APOE—age related macular degeneration	1.32e-05	0.000102	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—KDR—age related macular degeneration	1.29e-05	0.0001	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—C3—age related macular degeneration	1.26e-05	9.75e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—CD36—age related macular degeneration	1.24e-05	9.64e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—APOE—age related macular degeneration	1.17e-05	9.07e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—KDR—age related macular degeneration	1.15e-05	8.89e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CCL2—age related macular degeneration	1.11e-05	8.61e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—APOE—age related macular degeneration	1.1e-05	8.51e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CD36—age related macular degeneration	1.08e-05	8.35e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—VEGFA—age related macular degeneration	1.06e-05	8.23e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—VEGFA—age related macular degeneration	1.04e-05	8.08e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—LIPC—age related macular degeneration	9.97e-06	7.73e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—VEGFA—age related macular degeneration	9.89e-06	7.67e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—VEGFA—age related macular degeneration	9.87e-06	7.65e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CCL2—age related macular degeneration	9.84e-06	7.63e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CETP—age related macular degeneration	9.62e-06	7.46e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—APOE—age related macular degeneration	9.5e-06	7.37e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CD36—age related macular degeneration	9.38e-06	7.28e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CD36—age related macular degeneration	8.84e-06	6.86e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—VEGFA—age related macular degeneration	8.7e-06	6.75e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—APOE—age related macular degeneration	8.28e-06	6.42e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—APOE—age related macular degeneration	7.8e-06	6.05e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—VEGFA—age related macular degeneration	7.13e-06	5.53e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—VEGFA—age related macular degeneration	6.32e-06	4.9e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CD36—age related macular degeneration	5.78e-06	4.48e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—APOE—age related macular degeneration	5.1e-06	3.95e-05	CbGpPWpGaD
